Circulating tumor DNA dynamics and mutational profiles as indicators in neoadjuvant chemoimmunotherapy for resectable or borderline resectable non-small cell lung cancer
Neoadjuvant chemoimmunotherapy has reshaped the treatment landscape for non-small cell lung cancer (NSCLC), yet critical gaps remain in real-time monitoring and personalized adaptation. In this observational study, patients were evaluated via imaging and multidisciplinary review for subsequent surgery or r...